Procalcitonin as a prognostic marker for sepsis: A prospective observational study

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Jain, Saransh ^a   Sinha, Sanjeev ^a   Sharma, Surendra K ^a   Samantaray, J C ^a   Aggrawal, Praveen ^a   Vikram, Naval Kishore ^a   Biswas, Ashutosh ^a   Sood, Seema ^a   Goel, Manish ^a   Das, Madhuchhanda ^a   Vishnubhatla, Sreenivas ^a   Khan, Nawaid ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

C reactive protein; Procalcitonin; Prognosis; Sepsis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCITONIN; PROCALCITONIN; PROTEIN PRECURSOR;

ADULT; AGED; BACTERIA; BLOOD; CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INDIA; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; KAPLAN MEIER METHOD; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEPSIS; STATISTICS AND NUMERICAL DATA; TERTIARY CARE CENTER; TIME;

ADULT; AGED; BACTERIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INDIA; INTENSIVE CARE UNITS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY; SEPSIS; TERTIARY CARE CENTERS; TIME FACTORS;

EID: 84904275107     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-458     Document Type: Article

References (29)

1. SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent J-L, Ramsay G, Intensive Care Med 2001 2003 29 530 538
2. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP, JAMA 1995 273 117 123
3. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret G-Y, Crit Care Med 2006 34 1996 2003 (Pubitemid 43982479)
4. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Bouadma L, Luyt C-E, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, Bernard M, Pasquet B, Régnier B, Brun-Buisson C, Chastre J, Wolff M, Lancet 2010 375 463 474
5. Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? Giamarellos- Bourboulis EJ, Mega A, Grecka P, Scarpa N, Koratzanis G, Thomopoulos G, Giamarellou H, Intensive Care Med 2002 28 1351 1356 (Pubitemid 35025058)
6. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Nylen ES, Whang KT, Snider RH Jr, Steinwald PM, White JC, Becker KL, Crit Care Med 1998 26 1001 1006 (Pubitemid 28272848)
7. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent J-L, Moreno R, Crit Care Med 2013 41 580 637
8. The epidemiology of sepsis in the United States from 1979 through 2000. Martin GS, Mannino DM, Eaton S, Moss M, N Engl J Med 2003 348 1546 1554 (Pubitemid 36437931)
9. Early prognosis in patients with community-acquired severe sepsis and septic shock: analysis of 184 consecutive cases. Grozdanovski K, Milenkovic Z, Demiri I, Spasovska K, Cvetanovska M, Kirova-Urosevic V, Prilozi 2012 33 105 116
10. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, Mercier JC, Offenstadt G, Régnier B, JAMA 1995 274 968 974
11. Etiology of illness in patients with severe sepsis admitted to the hospital from the Emergency Department. Heffner AC, Horton JM, Marchick MR, Jones AE, Clin Infect Dis 2010 50 814 820
12. Efficacy and safety of recombinant human activated protein C for severe sepsis. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr, N Engl J Med 2001 344 699 709 (Pubitemid 32204987)
13. Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. Bates DW, Sands K, Miller E, Lanken PN, Hibberd PL, Graman PS, Schwartz JS, Kahn K, Snydman DR, Parsonnet J, Moore R, Black E, Johnson BL, Jha A, Platt R, J Infect Dis 1997 176 1538 1551
14. Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock. Artero A, Zaragoza R, Camarena JJ, Sancho S, González R, Nogueira JM, J Crit Care 2010 25 276 281
15. Serum procalcitonin at the time of admission to the ICU as a predictor of short-term mortality. Meng F-S, Su L, Tang Y-Q, Wen Q, Liu Y-S, Liu Z-F, Clin Biochem 2009 42 1025 1031
16. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Clec'h C, Fosse J-P, Karoubi P, Vincent F, Chouahi I, Hamza L, Cupa M, Cohen Y, Crit Care Med 2006 34 102 107 (Pubitemid 43032386)
17. Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Karlsson S, Heikkinen M, Pettilä V, Alila S, Väisänen S, Pulkki K, Kolho E, Ruokonen E, Crit Care 2010 14 205
18. Procalcitonin as a prognosis marker for the severe sepsis and septic shock patients in Emergency Department. Choi SW, Kim H, Kim KH, Shin DW, Park JS, Roh JY, Park JM, Korean J Critical Care Med 2011 26 250
19. Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Dahaba AA, Br J Anaesth 2006 97 503 508 (Pubitemid 44419965)
20. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Heper Y, Akaln EH, Mstk R, Akgöz S, Töre O, Göral G, Oral B, Budak F, Helvac S, Eur J Clin Microbiol Infect Dis 2006 25 481 491
21. Plasma levels of procalcitonin and neopterin in multiple trauma patients with or without brain injury. Sauerland S, Hensler T, Bouillon B, Rixen D, Raum MR, Andermahr J, Neugebauer EAM, J Neurotrauma 2003 20 953 960 (Pubitemid 37288555)
22. Procalcitonin and C-reactive protein in infective endocarditis: correlation with etiology and prognosis. Kocazeybek B, Küçü koǧlu S, Oner YA, Chemotherapy 2003 49 76 84 (Pubitemid 36469802)
23. Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study. Giamarellou H, Giamarellos-Bourboulis EJ, Repoussis P, Galani L, Anagnostopoulos N, Grecka P, Lubos D, Aoun M, Athanassiou K, Bouza E, Devigili E, Krçmery V, Menichetti F, Panaretou E, Papageorgiou E, Plachouras D, Clin Microbiol Infect 2004 10 628 633 (Pubitemid 39077050)
24. Procalcitonin as a marker of severity in septic shock. Schröder J, Staubach K-H, Zabel P, Stüber F, Kremer B, Langenbeck's Arch Surg 1999 384 33 38 (Pubitemid 29225315)
25. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Claeys R, Vinken S, Spapen H, Ver Elst K, Decochez K, Huyghens L, Gorus FK, Crit Care Med 2002 30 757 762 (Pubitemid 34297790)
26. International guidelines of the Surviving Sepsis Campaign: Update 2012. Briegel J, Möhnle P, Anaesthesist 2013 62 304 309
27. Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Pettila V, Hynninen M, Takkunen O, Kuusela P, Valtonen M, Intensive Care Med 2002 28 1220 1225 (Pubitemid 35025038)
28. Is C-reactive protein a good prognostic marker in septic patients? Silvestre J, Póvoa P, Coelho L, Almeida E, Moreira P, Fernandes A, Mealha R, Sabino H, Intensive Care Med 2009 35 909 913
29. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. Snider RH Jr, Nylen ES, Becker KL, J Investig Med 1997 45 552 560 (Pubitemid 127806489)